Actrapid and Capecitabine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actrapid (insulin) and Capecitabine (capecitabine). Common drug interactions include escherichia infection among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Actrapid and Capecitabine. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Actrapid?

Actrapid has active ingredients of insulin. eHealthMe is studying from 4,864 Actrapid users. Check the latest studies of Actrapid.

What is Capecitabine?

Capecitabine has active ingredients of capecitabine. eHealthMe is studying from 59,495 Capecitabine users. Check the latest studies of Capecitabine.

On Jul, 10, 2026

21 people who take Actrapid and Capecitabine together, and have interactions are studied.

Actrapid and Capecitabine drug interactions.

What are the common drug interactions of Actrapid and Capecitabine, by gender? *:

female:

Escherichia infection (bacterial infection by escherichia coli)
Hyperglycaemia (high blood sugar)
Sepsis (a severe blood infection that can lead to organ failure and death)
Haematoma (collection of blood outside the blood vessels)
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Type 1 diabetes mellitus
Death
Renal failure (kidney dysfunction)
Intestinal obstruction
Urinary tract infection

male:

Death
Pneumonia
Renal impairment (severely reduced kidney function)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Type 2 diabetes mellitus
Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Pleural effusion (water on the lungs)
Postrenal failure (postrenal acute renal failure)
Asthenia (weakness)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the common drug interactions of Actrapid and Capecitabine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Haematoma (collection of blood outside the blood vessels)

60+:

Escherichia infection (bacterial infection by escherichia coli)
Hyperglycaemia (high blood sugar)
Type 1 diabetes mellitus
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Malaise (a feeling of general discomfort or uneasiness)
Renal impairment (severely reduced kidney function)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Type 2 diabetes mellitus
Urinary tract infection
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 7 people, 33.33%
Diabetes: 7 people, 33.33%
Breast Cancer: 5 people, 23.81%
Colon Cancer: 5 people, 23.81%
Diarrhea: 3 people, 14.29%
Constipation: 3 people, 14.29%
Depression: 3 people, 14.29%
Stress And Anxiety: 3 people, 14.29%
High Blood Pressure: 3 people, 14.29%
Hyperthyroidism (over activity of the thyroid gland): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Actrapid and Capecitabine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously